The Faculty of Health and Medical Sciences at the University of Copenhagen houses 13 departments, 31 centres, five schools, four hospitals, and three libraries.
H. Lundbeck A/S is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.
Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 kms from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).
Matthias Mann is a scientist in the area of mass spectrometry and proteomics.
Medicon Valley Alliance is the Danish-Swedish cluster organisation representing human life sciences in the cross-border region of Medicon Valley. As a non-profit member organisation, Medicon Valley Alliance (MVA) carries out initiatives on behalf of the local life science community in order to create new research and business opportunities – initiatives which members would not be able to implement individually, and with the aim of strengthening the development of Medicon Valley.
Camurus AB (publ) is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Profound Pharma A/S was a Danish company that develops 2nd generation biopharmaceuticals.
Christian Karsten Hansen is a Danish biotechnology entrepreneur, investor and inventor, with work in new drugs, molecular biology and biochemistry.
LifeArc is a British life science medical research charity. It was established in 2000 as MRC Technology to translate the work of UK Medical Research Council (MRC) research scientists.
Biopeople – Denmark's Life Science Cluster is a publicly funded partnership and National Center established, authorized and funded by the Ministry for Science and Higher Education. It's aim is to improve innovation, collaboration and education within the National Danish Innovation System. Biopeople is established as a Center at the Faculty of Health and Medical Sciences at University of Copenhagen.
The North East of England Process Industry Cluster (NEPIC) is an economic cluster developed in accordance with Michael Porter's theories and strategies regarding industrial clusters. The chemistry-using sectors in North East England, where more than 1,400 businesses are headquartered in the industry's supply chain, formed this Process Industry Cluster. In the north-east of England, the industry employs approximately 35,000 direct workers and around 190,000 indirect workers, who collectively account for more than one-third of the area's industrial economy. Companies in the cluster produce 35% of the pharmaceuticals and 50% of the petrochemicals used in the UK, making this area the only net exporter of goods from the country. The area has more than £13 billion in exports.
The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people. It contributes to 5.7% of the gross domestic product of Switzerland and contributes to 30% of the country's exports. In 2017 about 30% of Swiss exports were chemical products. In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion.
Novo Holdings A/S is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's assets, which in 2022 was worth almost DKK 805 billion Danish Kroner and is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor. Novo Holdings A/S is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore.
Medicon Village is a life science research park in Lund, Sweden. It is located on the eastern outskirts of Lund University.
Eva Steiness née Uhl is a Danish physician, former university professor and businessperson who has been active in Scandinavia's pharmaceutical industry since the late 1990s. She is currently CEO of Serodus ASA, a biomedical company based in Oslo which develops drugs for the treatment of diabetes. In 1982, Steiness became the first women to be appointed dean of Copenhagen University's faculty of medicine and in 1985, she became the first women in Denmark to become a full professor in the medical field with her appointment at Aarhus University.
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley.
